Welcome to Pathognomia Podcast 🎙️ — where we decode complex guidelines into practical bedside wisdom.

In this episode, we take a deep dive into the GINA 2025 Asthma Guidelines, exploring what every clinician, resident, and student must know. From the paradigm-shifting “no SABA-only” approach to practical stepwise therapy, this episode breaks down the science, evidence, and real-world implications of modern asthma management.

We’ll cover:

Why SABA monotherapy is no longer recommended 🚫

The role of ICS-formoterol as both reliever and controller

Updated stepwise management across mild to severe asthma

Special situations: pediatrics, elderly, comorbidities, and pregnancy

Key trial evidence (SYGMA, Novel START, PRACTICAL) shaping these changes.

How to implement GINA 2025 in OPD, ER, and ICU practice

Whether you’re preparing for exams, polishing your clinical acumen, or simply keeping up-to-date with global respiratory standards — this episode will give you clarity, confidence, and clinically actionable knowledge.

Disclaimer:

This podcast is AI-generated educational content, curated from authentic, evidence-based sources including GINA 2025 guidelines and landmark clinical trials. It is intended for healthcare professionals and medical students. While every effort is made to ensure accuracy, listeners are advised to cross-check with official guidelines and exercise clinical judgment before applying this information. This is not a substitute for professional medical advice.